CAPR · Categories · Upgrades
CAPR - Analyst upgrades
Capricor Therapeutics Inc. (CAPR) analyst upgrades - real-time wire coverage filtered to Upgrades only.
Recent Upgrades for CAPR
- Capricor Therapeutics upgraded by B. Riley Securities with a new price targetB. Riley Securities upgraded Capricor Therapeutics from Neutral to Buy and set a new price target of $21.00
- Capricor Therapeutics upgraded by Piper Sandler with a new price targetPiper Sandler upgraded Capricor Therapeutics from Neutral to Overweight and set a new price target of $25.00
- Capricor Therapeutics upgraded by Oppenheimer with a new price targetOppenheimer upgraded Capricor Therapeutics from Perform to Outperform and set a new price target of $54.00
- Capricor Therapeutics upgraded by Cantor Fitzgerald with a new price targetCantor Fitzgerald upgraded Capricor Therapeutics from Neutral to Overweight and set a new price target of $28.00
Other CAPR categories
Is something on this page wrong? Request a change